NCT05196295 To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement. Status UNKNOWN Phase PHASE1
NCT05168215 Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. Status RECRUITING Phase N/A
NCT05148806 Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies Status COMPLETED Phase N/A
NCT05116215 To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement Status UNKNOWN Phase PHASE1
NCT05098600 The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic Status COMPLETED Phase N/A
NCT05085444 A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma Status UNKNOWN Phase EARLY_PHASE1
NCT05085431 A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome Status UNKNOWN Phase EARLY_PHASE1
NCT05085418 A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis Status UNKNOWN Phase EARLY_PHASE1
NCT05069714 One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. Status COMPLETED Phase PHASE3
NCT05030779 A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus Status UNKNOWN Phase EARLY_PHASE1
NCT05026892 Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases Status UNKNOWN Phase N/A
NCT05016700 Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders Status COMPLETED Phase N/A
NCT04902807 Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation Status RECRUITING Phase N/A
NCT04872257 Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo Status COMPLETED Phase NA
NCT04870411 Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics Status TERMINATED Phase N/A